1. Home
  2. WYY vs ANIX Comparison

WYY vs ANIX Comparison

Compare WYY & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo WidePoint Corporation

WYY

WidePoint Corporation

HOLD

Current Price

$10.75

Market Cap

107.8M

Sector

Technology

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.46

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WYY
ANIX
Founded
1991
1982
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
107.8M
88.8M
IPO Year
2005
2013

Fundamental Metrics

Financial Performance
Metric
WYY
ANIX
Price
$10.75
$2.46
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$8.67
$8.67
AVG Volume (30 Days)
144.6K
100.0K
Earning Date
05-14-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
12.82
EPS
0.01
N/A
Revenue
$150,545,364.00
$210,000.00
Revenue This Year
$14.41
N/A
Revenue Next Year
$11.41
N/A
P/E Ratio
$1,127.00
N/A
Revenue Growth
5.59
N/A
52 Week Low
$2.80
$2.44
52 Week High
$12.25
$5.46

Technical Indicators

Market Signals
Indicator
WYY
ANIX
Relative Strength Index (RSI) 61.27 33.67
Support Level $4.76 $2.44
Resistance Level N/A $3.13
Average True Range (ATR) 1.20 0.14
MACD -0.04 -0.03
Stochastic Oscillator 59.88 2.56

Price Performance

Historical Comparison
WYY
ANIX

About WYY WidePoint Corporation

WidePoint Corp is a provider of Technology Management as a Service (TMaaS) that consists of federally certified communications management, identity management, interactive bill presentment and analytics, and an Information Technology as a Service solution. Its solutions include Telecom Lifecycle Management, Digital billing communications solutions, and Mobile and Identity management. Geographically, the company generates a majority of its revenue from the United States and the rest from Europe.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: